Olema Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 07, 2023 at 04:13 pm EST
Olema Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 21.5 million compared to USD 22.72 million a year ago. Basic loss per share from continuing operations was USD 0.48 compared to USD 0.57 a year ago.
For the nine months, net loss was USD 69.88 million compared to USD 78.61 million a year ago. Basic loss per share from continuing operations was USD 1.66 compared to USD 1.97 a year ago.